Research Platforms
Research platforms support the Moon Shots Program. They are the foundation that strengthen our research and clinical advancements so we can go beyond discovery, better and faster.
Research to end cancers
Our research engines help us find effective treatment and prevention approaches - and quickly. The platforms in our arsenal streamline clinical trials, explore combination treatments and improve patient care.
/content/mda/en/cancermoonshots/research_platforms
Expand Image
News Release 08/13/2018
MD Anderson launches company to develop neuroprotective medicines
Company to explore new treatments uncovered by MD Anderson's Therapeutics Discovery team
Read More View All NewsResearch Fast. And Then Faster.
The research engines of the Moon Shots Program® allow us to rapidly translate findings into effective treatment and prevention approaches. Providing scientific expertise and specialized infrastructure to support the program, the platforms are deeply involved in flagship projects for Moon Shot® initiatives, advancing the latest clinical trials on new drugs, immunotherapies and combination treatments to achieve vastly improved patient care and save lives.
Molecular Diagnosis
We use platforms to generate and analyze data at the molecular level to better understand, detect and treat cancer. Because sometimes the biggest changes start small.
Improving Patient Care & Research
Our framework's structure and aggregate patient data increase research productivity and to improve patient care and research. This frees up researchers to focus on new theories, for new progress.
Prevention Research & Outreach
The research engine that informs and educates. We use community-based efforts to influence people to screen, detect early and avoid certain behaviors to prevent cancer before it even starts.
Drug Development
Entities dedicated to developing new drugs to help cure cancers faster - and more safely, too. Our aim is to translate discoveries into usable drugs (and cures) quickly and effectively.
Neurodegeneration Research
Innovative program exploring the connections between neurodegenerative diseases such as Alzheimer’s and Parkinson’s and cancer-related cognitive and neurological disorders in order to develop new therapies.